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INTRODUCTION
The incidence of preoperative hydronephrosis in patients
with bladder cancer ranges from 7.2 to 54.1% (1, 2). Although
pathologic stage and lymph node (LN) status are known to
be the most important prognostic factors, the prognostic sig-
nificance of preoperative hydronephrosis after radical cystec-
tomy has been investigated in other studies with conflicting
results (3-7). Some researchers have shown that preoperative
hydronephrosis is related to poor survival while others have
suggested that it is not a prognostic factor in multivariate
analysis. To our knowledge, the relationship between the sever-
ity of preoperative hydronephrosis and prognosis after radi-
cal cystectomy has not yet been evaluated. Therefore, in this
study, we investigated whether the presence and severity of
preoperative hydronephrosis have prognostic significance in
patients who underwent radical cystectomy for transitional
cell carcinoma (TCC) of the bladder.
MATERIALS AND METHODS
We performed a retrospective review of 457 patients who
underwent radical cystectomy and urinary diversion for blad-
der cancer at our institution between 1986 and 2005. Fifth-
one patients with non-TCC pathology, upper urinary tract
carcinoma, obstructing stones, neoadjuvant chemotherapy
or radiotherapy, incomplete medical records were excluded. 
Preoperative hydronephrosis was defined as dilation of the
ureter and renal pelvis with or without secondary changes in
the renal parenchyma, diagnosed by computed tomography
(CT) or renal ultrasound. All CT and ultrasound images were
reviewed by a uroradiologist. Based on the Society for Fetal
Urology (SFU) grading system (8), the patients without calyx
or pelvic dilation were classified as grade 0, pelvic dilation
only as grade 1, and the tumors accompanying mild calyx
dilation as grade 2. Patients with severe calyx dilation were
classified as grade 3, and tumors with calyx dilation accom-
panied by renal parenchymal atrophy as grade 4. Then, cases
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High-Grade Hydronephrosis Predicts Poor Outcomes After Radical
Cystectomy in Patients with Bladder Cancer 
We examined whether the presence and severity of preoperative hydronephrosis
have prognostic significance in patients who underwent radical cystectomy for tran-
sitional cell carcinoma of the bladder. The medical records of 457 patients who under-
went radical cystectomy for bladder cancer between 1986 and 2005 were retrospec-
tively reviewed. Following the Society for Fetal Urology grading system, patients
were divided into low-, and high-grade hydronephrosis groups. Clinicopathologic
factors associated with preoperative hydronephrosis and survival were evaluated.
Of a total of 406 patients, unilateral hydronephrosis was found in 74 (18.2%), bilat-
eral hydronephrosis in 11 (2.7%), and no hydronephoris in 321 (79.1%). Low-grade
hydronephrosis was found in 57 (12.2%) patients and high-grade hydronephrosis
in 28 (6%). Preoperative hydronephrosis was related to higher pT stage and lymph
node invasion. In univariate analysis, the presence of hydronephrosis, hydronephro-
sis grade, age, pT and pN stage, tumor grade, surgical margin, number of retrieved
nodes, carcinoma in situ, and lymphovascular invasion were significant prognostic
factors for cancer-specific survival. In multivariate analysis, bilateral hydronephro-
sis and high-grade hydronephrosis remained significant predictors for decreased
survival. The presence of preoperative hydronephrosis, and high-grade hydronephro-
sis are significant prognostic factors in patients with bladder cancer after radical cys-
tectomy.
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were divided into low- and high-grade hydronephrosis groups.
The low-grade hydronephrosis group included patients with
SFU grade 1 or 2 hydronephrosis, and the high-grade hydro-
nephrosis group included those with SFU grade 3 or 4 hydro-
nephrosis. 
All patients had a complete preoperative evaluation includ-
ing physical examination, complete blood count, serum cre-
atinine, electrolyte analysis, chest radiography, abdominal
ultrasound, CT and bone scan. All patients underwent a bilat-
eral pelvic lymphadenectomy to the bifurcation of the com-
mon iliac vessels. 
Pathologic T and N stage, margin status, tumor grade,
carcinoma in situ (CIS), lymphovascular invasion (LVI), and
squamous differentiation were recorded. Pathologic staging
was done according to the 2002 tumor node metastasis (TNM)
classification. During the median follow-up duration of 66.3
months (range, 3-232 months), patients were examined every
3 months for the first 2 yr, and 6-months intervals for 5 yr,
and annually thereafter. Clinicopathologic factors associated
with preoperative hydronephrosis were evaluated by chi-square
test. Cancer-specific survival curves were calculated by Kaplan-
Meier method. Univariate and multivariate analysis were per-
formed using log rank test and Cox proportional hazards mo-
del. Statistical analysis was performed using SPSS version 12.0
and significance was defined as P<0.05. 
RESULTS
The study group was composed of 360 men and 46 women
and the median age was 60.8 yr (range, 27-79 yr). Of a total
of 406 patients, unilateral hydronephrosis was found in 74
(18.2%), bilateral hydronephrosis in 11 (2.7%), and no hyd-
ronephrosis in 321 (79.1%). Low-grade hydronephrosis was
found in 57 (12.2%) patients and high-grade hydronephro-
sis in 28 (6%). Clinicopathologic characteristics of all patients
are shown in Table 1. 
Chi-square test was performed to determine whether there
was a correlation between the presence and severity of preop-
erative hydronephrosis and clinicopathologic factors. The pres-
ence of preoperative hydronephrosis was related to higher pT
stage (≥T3), LN invasion, positive surgical margin, higher
tumor grade, presence of LVI, and squamous differentiation.
The severity of preoperative hydronephrosis was related to
higher pT stage (≥T3), LN invasion, positive surgical mar-
gin, presence of LVI, and squamous differentiation (Table 2). 
The mean cancer-specific survival of all patients was 49.5
months (range, 3-232 months). The 3- and 5-yr cancer-spe-
cific survival rates, estimated by the Kaplan-Meier method,
were 75.5% and 69.3%, respectively. When the study pop-
ulation was divided into 3 groups based on the hydronephro-
sis status, patients without preoperative hydronephrosis show-
ed a better median cancer-specific survival (52 months; range,
3-232 months) compared to those with unilateral hydrone-
prhosis (42 months; range, 3-207 months; P=0.002) or bilat-
eral hydronephrosis (17 months; range, 3-76 months; P<
0.001) by log rank test (Fig. 1A). When the patients were
placed into 3 groups based on hydronephrosis grade, patients
without preoperative hydronephrosis showed a better medi-
an cancer-specific survival (52 months; range, 3-232 months)
compared to those with low-grade hydronephrosis (41 months;
SFU, Society of Fetal Urology; pT, pathologic T; pN, pathologic N; CIS,
carcinoma in situ; LVI, lymphovascular invasion.
Characteristics No. of patients (%)
Gender
Male 360 (88.7)
Female 46 (11.3)
Age
<60 yr 196 (48.3)
≥60 yr 210 (51.7)
Hydronephrosis
No 321  (79.1)
Unilateral 74 (18.2)
Bilateral 11 (2.7)
Hydronephrosis grade (SFU system)
Grade 0 321 (79.1)
Grade 1 11 (2.7)
Grade 2 46 (11.3)
Grade 3 21 (5.2)
Grade 4 7 (1.7)
pT stage
Ta, T1  137 (33.7)
T2 136 (33.5)
T3 104 (25.6)
T4 29 (7.2)
pN stage
0 357  (87.9)
1-3 49 (12.1)
Tumor grade
Low 87 (21.4)
High 319 (78.6)
Surgical margin
Negative 390 (96.1)
Positive 16  (3.9)
Number of retrieved nodes
<12 122 (30)
≥12 284 (70)
CIS
Absent 319 (78.6)
Present 87 (21.4)
LVI
Absent 343 (84.5)
Present 63 (15.5)
Squamous differentiation
Absent 367 (90.4)
Present 39 (9.6)
Total 406
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range, 3-184 months; P=0.021) or high-grade hydronephro-
sis (20 months; range, 3-232 months; P<0.001) by log rank
test (Fig. 1B). In univariate analysis of other clinicopathologic
variables, patient age (<60 yr vs. ≥60 yr; P=0.048), T stage
(Ta-2 vs. T3-4; P<0.001), N stage (N0 vs. N1-3; P<0.001),
tumor grade (low vs. high, P=0.002), surgical margin posi-
tivity (P=0.001), number of retrieved nodes (<12 vs. ≥12;
P<0.001), CIS (P=0.025), and LVI (P<0.001) were signifi-
cant prognostic factors for cancer-specific survival after radi-
cal cystectomy. In multivariate analysis performed using a
Cox proportional hazards regression model, bilateral hydro-
nephrosis (hazard ratio [HR] 7.16; P<0.001) as well as high
grade hydronephrosis (HR 2.20; P=0.003) remained signif-
icant predictors for decreased survival when controlled for
Unilateral Bilateral No 
Tumor factors
P
value
Hydronephrosis
pT stage
Low (Ta-2) 236 (86.4%) 30 (11.0%) 7 (2.6%) <0.001 236 (86.4%) 27 (9.9%) 10 (3.7%) <0.001
High (T3-4) 85 (63.9%) 44 (33.1%) 4 (3.0%) 85 (63.9%) 30 (22.6%) 18 (13.5%)
pN stage
N0 288 (80.7%) 60 (16.8%) 9 (2.5%) 0.099 288 (80.7%) 47 (13.2%) 22 (6.2%) 0.087
N+ 33 (67.3%) 16 (28.6%) 2 (4.1%) 33 (67.3%) 10 (20.4%) 6 (12.2%)
Tumor grade
Low  77 (88.5%) 9 (10.3%) 1 (1.1%) 0.049 77 (88.5%) 7 (8.0%) 3 (3.4%) 0.050
High 244 (76.5%) 65 (20.4%) 10 (3.1%) 244 (76.5%) 50 (15.7%) 25 (7.8%)
Surgical margins
Negative 313 (80.3%) 67 (17.2%) 10 (2.6%) 0.014 313 (80.3%) 51 (13.1%) 26 (6.7%) 0.011
Positive 8 (50%) 7 (43.8%) 1 (6.3%) 8 (50%) 6 (37.5%) 2 (12.5%)
CIS
Absent 246 (77.1%) 62 (19.4%) 11 (3.4%) 0.086 246 (77.1%) 48 (15.0%) 25 (7.8%) 0.157
Present 75 (86.2%) 12 (13.8%) 0 (0%) 75 (86.2%) 9 (10.3%) 3 (3.4%)
LVI
Absent 279 (81.3%) 57 (16.6%) 7 (2.0%) 0.016 279 (81.3%) 43 (12.5%) 21 (6.1%) 0.031
Present 42 (66.7%) 17 (27.0%) 4 (6.3%) 42 (66.7%) 14 (22.2%) 7 (11.1%)
Squamous differentiation
Absent 297 (80.9%) 60 (16.3%) 10 (2.7%) 0.011 297 (80.9%) 49 (13.4%) 21 (5.7%) 0.005
Present 24 (61.5%) 14 (35.9%) 1 (2.6%) 24 (61.5%) 8 (20.5%) 7 (17.9%)
Low    High No 
P
value
Hydronephrosis grade
Table 2. Correlation between clinicopathologic factors and preoperative hydronephrosis 
Fig. 1. Cancer-specific survival curves (A) for patients without hydronephrosis, with unilateral hydronephrosis, and with bilateral hydronephro-
sis and (B) for patients without hydronephrosis, with low-grade hydronephrosis, and with high-grade hydronephrosis. 
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age, pathologic T (pT) and pathologic N (pN) stage, surgi-
cal margin positivity, number of retrieved nodes, and LVI
(Table 3). 
We also analyzed 269 patients with muscle invasive blad-
der cancer excluding patients with non-muscle invasive blad-
der cancer (pTa-1), and compared between organ confined
disease (T2) and non-organ confined disease (≥T3). The mean
cancer-specific survival of 269 patients with muscle invasive
bladder cancer was 55.03 months (range, 3-227 months). The
presence and severity of preoperative hydronephrosis was asso-
ciated with non-organ confined disease. When the study pop-
ulation was divided into 3 groups based on the hydronephro-
sis status, patients with bilateral hydronephrosis showed a
poorer median cancer-specific survival (16 months) compared
to those with no hydronephrosis (41 months; P<0.001) or
unilateral hydronephrosis (37.5 months; P=0.007) by log
rank test. But there was no difference in cancer-specific sur-
vival between no hydronephrosis and unilateral hydronephro-
sis groups (P=0.322). When the patients were splitted into
3 groups based on hydronephrosis grade, patients with high-
grade hydronephrosis showed a poorer median cancer-specific
survival (18 months) compared to those with no hydrone-
phrosis (41 months; P=0.003) or low-grade hydronephrosis
(37.5 months; P=0.048) by log rank test. There was no dif-
ference in cancer-specific survival between no hydronephrosis
and high-grade hydronephrosis groups (P=0.625). In multi-
variate analysis, bilateral hydronephrosis (HR 4.84; P<0.001)
as well as high grade hydronephrosis (HR 1.78; P=0.030)
were significant predictors for decreased survival when con-
trolled for pT and pN stage, surgical margin positivity, num-
ber of retrieved nodes, and LVI.
DISCUSSION 
In addition to TNM stage, known as the most important
prognostic factor in patients who underwent radical cystec-
tomy for bladder TCC, clinicopathologic factors such as pati-
ent age, LVI, and CIS have been reported as significant pre-
dictors (9, 10). However, many studies have presented differ-
ent results regarding the significance of preoperative hydro-
nephrosis. Haleblian et al. (3) analyzed 415 patients and found
that bilateral preoperative hydronephrosis has a significant
relation to increased stage and overall survival. Leibovitch et
al. (1) studied 122 cases and reported that patients without
preoperative hydronephrosis had better cancer-specific sur-
vival compared to those with preoperative hydronephrosis.
They suggested that hydronephrotic patients with ureteral
orifice involvement of bladder cancer on cystoscopic finding
had a tendency to show low-stage disease compared to hyd-
ronephrotic patients without ureter orifice involvement. Bar-
tsch et al. (4) reported the similar findings, showing that hyd-
ronephrotic patients without tumors at the orifice on cysto-
scopy have a 70% risk of having non-organ confined disease
and a 40% risk of having LN metastasis compared to those
with tumors at the ureteral orifice, who have significantly lower
risks at 41.7% and 19.4%, respectively. They also reported
that preoperative hydronephrosis was an independent prog-
nostic factor for recurrence-free survival. Yang et al. (11) ana-
lyzed 310 patients and identified preoperative hydronephrosis
as an independent predictor for cancer-specific survival in uni-
variate analysis, but significance was not found in multivari-
ate analysis. Canter et al. (12) showed that bilateral hydro-
nephrosis was found to have a HR of 3.87 and 2.75 for dis-
ease-specific survival and overall survival, respectively on mul-
tivariate analysis.
This study included 406 patients with urothelial carcino-
ma of the urinary bladder and focused on the presence and
grade of preoperative hydronephrosis as prognostic factors
for cancer-specific survival. To our knowledge, this is the first
investigation to stratify hydronephrotic patients according
to the hydronephrosis grade and analyze the prognostic sig-
nificance of the hydronephrosis grade. The SFU grading sys-
tem, introduced in 1993, is a subjective, 5-point numerical
grading system that assigns a grade of 0 to 4 based on the
appearance of the calyces and renal pelvis and renal parenchy-
mal thickness (13). To clarify the differences between hyd-
HR, hazard ratio; CI, confidence interval; pT, pathologic T; pN, patho-
logic N; LVI, lymphovascular invasion.
HR Parameters 95% CI P value
Age
<60 yr 
≥60 yr 1.53 1.075-2.177 0.022
Hydronephrosis
No Reference
Unilateral 1.08 0.701-1.654 0.752
Bilateral 7.16 3.417-15.016 <0.001
Hydronephrosis grade 
No (grade 0) Reference
Low 0.99 0.607-1.624 0.978
High    2.20 1.309-3.710 0.003
pT stage
Ta-T2 
T3-T4 3.45 2.263-5.254 <0.001
pN stage
N0 
N1-N3 2.06 1.329-3.184 0.001
Surgical margin
Negative
Positive 2.66 1.325-5.345 0.006
Number of retrieved nodes
<12
≥12 1.98 1.360-2.885 <0.001
LVI
Absent
Present 1.53 1.013-2.323 0.043
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ronephrosis grades, patients with SFU grade 1 and 2 were
assigned to the low-grade group and those with SFU grade 3
and 4 to the high-grade group. The number of patients with
low-grade and high-grade hydronephrosis was 57 (14.0%)
and 28 (6.9%), respectively.
Bladder cancer that causes gradual ureteral orifice obstruc-
tion might result in the development of hydronephrosis. Con-
sequently, the degree of hydronephrosis and T stage might
be correlated. Although we found that high-grade or bilat-
eral hydronephrosis were related to the higher pT stage on
chi-square analysis, some patients with high-grade or bilat-
eral hydronephrosis showed non-muscle invasive bladder can-
cer. Among 28 patients with high-grade hydronephrosis and
11 patients with bilateral hydronephrosis, Ta-1 stage was found
in 3 and 2 patients, respectively.
The grade and presence of preoperative hydronephrosis were
significant predictors for cancer-specific survival on log-rank
test. In multivariate analysis, high-grade hydronephrosis and
bilateral hydronephrosis had an HR of 2.20 and 7.16 for can-
cer-specific survival, respectively. In addition, analysis of pati-
ents with muscle invasive bladder cancer (pT2-4) excluding
pTa-1, showed that high-grade hydronephrosis and bilateral
hydronephrosis were significant predictors with HR of 1.78
and 4.84 for cancer-specific survival.
This study has 2 limitations. First, it is a retrospective review,
which limits the power of its results. Second, cystoscopic eval-
uation of the bladder cancer was not involved in the analysis.
Tumor location related to the ureteral orifice could affect the
prognosis after radical cystectomy as shown by Leibovitch
et al. (1) and Bartsch et al. (4). Despite these limitations, our
data supports that preoperative hydronephrosis, especially the
grade of preoperative hydronephrosis is an independent pre-
dictor for cancer-specific survival in patients with bladder can-
cer after cystectomy.
In conclusion, the presence and high grade of preoperative
hydronephrosis are related to the higher pT stage and are sig-
nificant prognostic factors for cancer-specific survival in pati-
ents who underwent radical cystectomy for bladder cancer.
This could be helpful in deciding the therapeutic plans and
assessing the prognosis of patients before the operation. 
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